FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Lin, HH
   Himali, JJ
   Satizabal, CL
   Beiser, AS
   Levy, D
   Benjamin, EJ
   Gonzales, MM
   Ghosh, S
   Vasan, RS
   Seshadri, S
   McGrath, ER
AF Lin, Honghuang
   Himali, Jayandra J.
   Satizabal, Claudia L.
   Beiser, Alexa S.
   Levy, Daniel
   Benjamin, Emelia J.
   Gonzales, Mitzi M.
   Ghosh, Saptaparni
   Vasan, Ramachandran S.
   Seshadri, Sudha
   McGrath, Emer R.
TI Identifying Blood Biomarkers for Dementia Using Machine Learning Methods
   in the Framingham Heart Study
SO CELLS
LA English
DT Article
DE dementia; risk prediction; biomarkers; blood biomarkers; machine
   learning
ID MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SIGNALING PROTEINS;
   A-BETA; RISK; IDENTIFICATION; DIAGNOSIS; CLASSIFICATION; ASSOCIATION;
   CHOLESTEROL
AB Blood biomarkers for dementia have the potential to identify preclinical disease and improve participant selection for clinical trials. Machine learning is an efficient analytical strategy to simultaneously identify multiple candidate biomarkers for dementia. We aimed to identify important candidate blood biomarkers for dementia using three machine learning models. We included 1642 (mean 69 +/- 6 yr, 53% women) dementia-free Framingham Offspring Cohort participants attending examination, 7 who had available blood biomarker data. We developed three machine learning models, support vector machine (SVM), eXtreme gradient boosting of decision trees (XGB), and artificial neural network (ANN), to identify candidate biomarkers for incident dementia. Over a mean 12 +/- 5 yr follow-up, 243 (14.8%) participants developed dementia. In multivariable models including all 38 available biomarkers, the XGB model demonstrated the strongest predictive accuracy for incident dementia (AUC 0.74 +/- 0.01), followed by ANN (AUC 0.72 +/- 0.01), and SVM (AUC 0.69 +/- 0.01). Stepwise feature elimination by random sampling identified a subset of the nine most highly informative biomarkers. Machine learning models confined to these nine biomarkers showed improved model predictive accuracy for dementia (XGB, AUC 0.76 +/- 0.01; ANN, AUC 0.75 +/- 0.004; SVM, AUC 0.73 +/- 0.01). A parsimonious panel of nine candidate biomarkers were identified which showed moderately good predictive accuracy for incident dementia, although our results require external validation.
C1 [Lin, Honghuang; Himali, Jayandra J.; Satizabal, Claudia L.; Beiser, Alexa S.; Levy, Daniel; Benjamin, Emelia J.; Gonzales, Mitzi M.; Ghosh, Saptaparni; Vasan, Ramachandran S.; Seshadri, Sudha; McGrath, Emer R.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01701 USA.
   [Lin, Honghuang] Univ Massachusetts, Dept Med, Med Sch, Worcester, MA 01655 USA.
   [Himali, Jayandra J.; Beiser, Alexa S.; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.
   [Himali, Jayandra J.; Beiser, Alexa S.; Benjamin, Emelia J.; Ghosh, Saptaparni; Vasan, Ramachandran S.; Seshadri, Sudha] Boston Univ, Sch Med, Boston, MA 02118 USA.
   [Himali, Jayandra J.; Satizabal, Claudia L.; Gonzales, Mitzi M.; Seshadri, Sudha] Univ Texas Hlth Sci Ctr San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 77072 USA.
   [Levy, Daniel] NHLBIH, Populat Sci Branch, Bethesda, MD 20824 USA.
   [McGrath, Emer R.] Natl Univ Ireland Galway, HRB Clin Res Facil, Univ Rd, Galway H91 TK33, Ireland.
C3 Framingham Heart Study; University of Massachusetts System; University
   of Massachusetts Worcester; Boston University; Boston University;
   University of Texas System; University of Texas Health Science Center at
   San Antonio; Health Research Board - Ireland
RP McGrath, ER (corresponding author), Framingham Heart Dis Epidemiol Study, Framingham, MA 01701 USA.; McGrath, ER (corresponding author), Natl Univ Ireland Galway, HRB Clin Res Facil, Univ Rd, Galway H91 TK33, Ireland.
EM Honghuang.lin3@umassmed.edu; himali@uthsca.edu; satizabal@uthsca.edu;
   alexab@bu.edu; levyd@nhlbi.nih.gov; emelia@bu.edu;
   gonzalesM20@uthscsa.edu; sapta@bu.edu; vasan@bu.edu;
   seshadri@uthscsa.edu; emer.mcgrath@nuigalway.ie
RI Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011; Lin,
   Honghuang/A-3269-2019; Ghosh, Saptaparni/IUP-8657-2023
OI Levy, Daniel/0000-0003-1843-8724; Benjamin, Emelia/0000-0003-4076-2336;
   Satizabal, Claudia L/0000-0002-1115-4430; Ramachandran,
   Vasan/0000-0001-7357-5970; McGrath, Emer/0000-0002-3589-2964
FU Health Research Board of Ireland [CSF-2020-011]; Alzheimer's Association
   [AARG-NTF20-643020, AACSF-18-566570]; National Institute on Aging
   [U24NS100591, 1U01AG068221-01A1, R01 AG028321, R01 AG033193, R01
   AG008122, U01 AG049505, R01 AG049607, R01 AG054076, R01 AG059421, R01
   AG066524, U01 AG052409]; American Heart Association [20SFRN35360180];
   National Heart, Lung, and Blood Institute [HHSN268201500001,
   75N92019D00031]; NHLBI [1RO1 HL64753, R01 HL076784]; National Institute
   on Neurological Disorders and Stroke [R01 NS017950, UH2 NS100605];
   National Institute of Neurological Disorders and Stroke
FX ERM received funding from the Health Research Board of Ireland
   (CSF-2020-011) and the Alzheimer's Association (AACSF-18-566570) to
   support this work. HL received funding from the National Institute on
   Aging (1U01AG068221-01A1), the Alzheimer's Association (grant
   AARG-NTF20-643020), and the American Heart Association (Grant
   20SFRN35360180) to support this work. The Framingham Heart Study is
   supported by the National Heart, Lung, and Blood Institute contracts
   HHSN268201500001 and 75N92019D00031. Additional support for this work
   was provided by NHLBI grants 1RO1 HL64753 and R01 HL076784, grants from
   the National Institute on Aging (R01 AG028321, R01 AG033193, R01
   AG008122, U01 AG049505, R01 AG049607, R01 AG054076, R01 AG059421, R01
   AG066524, U01 AG052409), and the National Institute on Neurological
   Disorders and Stroke (R01 NS017950 and UH2 NS100605). The MarkVCID
   Consortium is funded by the National Institute of Neurological Disorders
   and Stroke and National Institute on Aging (U24NS100591).
NR 55
TC 5
Z9 6
U1 3
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAY
PY 2022
VL 11
IS 9
AR 1506
DI 10.3390/cells11091506
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1E8AM
UT WOS:000794704300001
PM 35563811
OA gold, Green Published
DA 2024-04-07
ER

EF